Serum Esterolytic Activity in a Wide Variety of Diseases
- 20 January 1966
- journal article
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 274 (3) , 129-133
- https://doi.org/10.1056/nejm196601202740302
Abstract
THERE have been several recent reports suggesting the diagnostic value of measuring the hydrolysis of two arginine substrates, benzoyl-L-arginine ethyl ester (BAEE)1 and benzoyl arginine amide (BAA)2 , 3 by serum of patients with acute pancreatitis and carcinoma of the pancreas. Although more than one component of serum has been shown to be capable of hydrolyzing these substrates, it has been suggested that trypsin may be elevated in pancreatic disease and could conceivably account for the enhanced hydrolysis of the arginine substrates. In any event, if significant hydrolysis could be established in one or both of these diseases, an appreciable diagnostic advance . . .Keywords
This publication has 8 references indexed in Scilit:
- Increased Plasma Proteolytic Activity Due to Arginine Amidase in Patients with PancreatitisNew England Journal of Medicine, 1963
- The PancreasGastroenterology, 1962
- Serum Proteolytic Enzyme Activity in Pancreatic DiseaseNew England Journal of Medicine, 1960
- The Trypsin Inhibitor Capacity of Serums in Normal and Diseased StatesAmerican Journal of Clinical Pathology, 1960
- Serum Exopeptidase Activity in Diseases of the PancreasNew England Journal of Medicine, 1959
- Serum TrypsinNew England Journal of Medicine, 1958
- SOME CONSIDERATIONS OF THE MULTIPLE SPECIFICITY OF PROTEOLYTIC ENZYMESAnnals of the New York Academy of Sciences, 1957
- Concerning the Mechanism of Complement ActionThe Journal of Immunology, 1956